Morning, Thursday, 1st October 2020
THIS EVENT IS CPD CERTIFIED
This conference looks at the future of health research in England.
Stakeholders in health research and policymakers will discuss:
- the balance of public and private sector funding - including the impact of any changes to the funding landscape;
- regulation of clinical trials as the EU prepares to implement Clinical Trials Regulation (CTR); and
- what more needs to be done to ensure the UK remains an attractive place to carry out research.
We also expect discussion on further developments in policy affecting the sector.
These include the update to the Life Sciences Industrial Strategy and its commitments to publishing a national genomics strategy, a national data policy framework to support research partnerships, and a common gateway for data access.
Further sessions look at the Medicines and Medical Devices Bill which aims to ensure the UK takes a key role in global research post-Brexit to develop advanced therapies and diagnostics to improve patient care, including commitments to:
- investment in science research and skills;
- remove barriers to the uptake of new innovations including adapting the process for low-risk clinical trials;
- support the development of the life sciences sector in the UK; and
- increase funding for dementia research.
The agenda includes a keynote address from:
- Professor David Crossman, Chief Scientist, Health, NHS Scotland.
Further keynote contributors include: John Craig, Care City; Amy Darlington, Imperial College Health Partners and Professor Matt Westmore, University of Southampton.
The chairs are: Lord Butler of Brockwell, Non-Executive Director, King’s Health Partners and Lord Sharkey, Chair, Association of Medical Research Charities.
The agenda in summary
- Priorities for health research policy in England;
- Encouraging research uptake - regulation, safeguarding data, and navigating the approval process:
- Regulation of research and clinical trials;
- Utilising data-protection, appropriate sharing, and maintaining public trust;
- Transparency in research - reproducibility, reporting results, and impact;
- Patient and public engagement in health research; and
- Opportunities for learning from the NHS Test Beds Programme - a case study.
- Health research and the research workforce - funding, the impact of Brexit, and encouraging cross-sector collaboration; and
- Ensuring the UK remains an attractive place to carry out clinical research.
Engagement with policy officials at this conference
Westminster Health Forum conferences typically attract strong interest from policymakers. This seminar will be an opportunity for stakeholders to engage with officials who have reserved places representing: the Office for Life Sciences; DHSC; DIT; HM Treasury; MHRA and The Scottish Government.